Insmed Inc. Stock
Insmed Inc. Stock
With 13 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 44 € shows a very positive potential of 83.33% compared to the current price of 24.0 € for Insmed Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insmed Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insmed Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | - | 0.840% | -6.250% | 40.351% | -16.084% | -9.091% | -5.882% |
| Ardelyx Inc. | -3.830% | 19.664% | 14.204% | 98.895% | 30.761% | 36.180% | - |
| Evolus Inc | 0.830% | 2.542% | 0.000% | 47.561% | 33.702% | 64.626% | - |
| Salarius Pharmaceuticals Inc. | -0.980% | -12.174% | -6.047% | -77.430% | -27.207% | -98.343% | -99.993% |
Comments
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
Show more
Ratings data for INSM provided by MarketBeat